| Diagnostics for SARS-CoV-2 infections BD Kevadiya, J Machhi, J Herskovitz, MD Oleynikov, WR Blomberg, ... Nature materials 20 (5), 593-605, 2021 | 855 | 2021 |
| Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ... Nature communications 10 (1), 2753, 2019 | 330 | 2019 |
| Creation of a long-acting nanoformulated dolutegravir B Sillman, AN Bade, PK Dash, B Bhargavan, T Kocher, S Mathews, H Su, ... Nature communications 9 (1), 443, 2018 | 130 | 2018 |
| A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy M Araínga, B Edagwa, RL Mosley, LY Poluektova, S Gorantla, ... Retrovirology 14, 1-13, 2017 | 118 | 2017 |
| Neurotheranostics as personalized medicines BD Kevadiya, BM Ottemann, MB Thomas, I Mukadam, S Nigam, ... Advanced Drug Delivery Reviews 148, 252-289, 2019 | 112 | 2019 |
| A year-long extended release nanoformulated cabotegravir prodrug TA Kulkarni, AN Bade, B Sillman, BLD Shetty, MS Wojtkiewicz, N Gautam, ... Nature materials 19 (8), 910-920, 2020 | 110 | 2020 |
| Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles T Zhou, H Su, P Dash, Z Lin, BLD Shetty, T Kocher, A Szlachetka, ... Biomaterials 151, 53-65, 2018 | 107 | 2018 |
| Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies B J Edagwa, T Zhou, JE M McMillan, XM Liu, H E Gendelman Current medicinal chemistry 21 (36), 4186-4198, 2014 | 104 | 2014 |
| Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human … P Puligujja, JE McMillan, L Kendrick, T Li, S Balkundi, N Smith, ... Nanomedicine: Nanotechnology, Biology and Medicine 9 (8), 1263-1273, 2013 | 100 | 2013 |
| Long-acting slow effective release antiretroviral therapy B Edagwa, JE McMillan, B Sillman, HE Gendelman Expert opinion on drug delivery 14 (11), 1281-1291, 2017 | 87 | 2017 |
| Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis G Shahnaz, BJ Edagwa, JE McMillan, S Akhtar, A Raza, NA Qureshi, ... Nanomedicine 12 (2), 99-115, 2017 | 87 | 2017 |
| EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment CJ Gu, A Borjabad, E Hadas, J Kelschenbach, BH Kim, W Chao, ... PLoS pathogens 14 (6), e1007061, 2018 | 76 | 2018 |
| Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research DA Cobb, NA Smith, BJ Edagwa, JEM McMillan Expert Opinion on Drug Delivery 17 (9), 1227-1238, 2020 | 70 | 2020 |
| Creation of a long-acting nanoformulated 2′, 3′-dideoxy-3′-thiacytidine D Guo, T Zhou, M Araínga, D Palandri, N Gautam, T Bronich, Y Alnouti, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 74 (3), e75-e83, 2017 | 62 | 2017 |
| Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs DP Gnanadhas, PK Dash, B Sillman, AN Bade, Z Lin, DL Palandri, ... The Journal of clinical investigation 127 (3), 857-873, 2017 | 59 | 2017 |
| Development and characterization of a long-acting nanoformulated abacavir prodrug D Singh, JE McMillan, J Hilaire, N Gautam, D Palandri, Y Alnouti, ... Nanomedicine 11 (15), 1913-1927, 2016 | 59 | 2016 |
| Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes BJ Edagwa, D Guo, P Puligujja, H Chen, JE McMillan, X Liu, ... The FASEB journal 28 (12), 5071, 2016 | 52 | 2016 |
| The promise of long-acting antiretroviral therapies: from need to manufacture HE Gendelman, JE McMillan, AN Bade, B Edagwa, BD Kevadiya Trends in microbiology 27 (7), 593-606, 2019 | 51 | 2019 |
| Multimodal theranostic nanoformulations permit magnetic resonance bioimaging of antiretroviral drug particle tissue-cell biodistribution BD Kevadiya, C Woldstad, BM Ottemann, P Dash, BR Sajja, B Lamberty, ... Theranostics 8 (1), 256, 2018 | 50 | 2018 |
| Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles DA Cobb, N Smith, S Deodhar, AN Bade, N Gautam, BLD Shetty, ... Nature communications 12 (1), 5458, 2021 | 49 | 2021 |
